Fernanda Arnaldez
0000-0003-1185-2498
Rutgers University Rutgers Business School
3 papers found
Refreshing results…
Phase II Study of Palbociclib (PD-0332991) inCCND1,2, or3Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B
A Phase II Trial of Guadecitabine in Children and Adults with SDH-Deficient GIST, Pheochromocytoma, Paraganglioma, and HLRCC-Associated Renal Cell Carcinoma
Modernizing Clinical Trial Eligibility Criteria: Recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group
Missing publications? Search for publications with a matching author name.